ADIPOQ and obesity disorder: It is unlikely that obesity was a contributor to the observed reduction in adiponectin levels in patients with premalignant oral lesions or in HNSCC patients that were treated with 1,25(OH)2D3 as there were no significance differences in the body mass index among any of the four groups of patients.